Fierce Pharma Asia—China’s IIT scrutiny; Daiichi Sankyo, AZ ph. 3 win; Leo, Tanabe’s dermatology deal
China’s investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of transparency.…
Browsing Tag